Provided by Tiger Fintech (Singapore) Pte. Ltd.

NovoCure

20.18
+0.92004.78%
Volume:925.40K
Turnover:18.49M
Market Cap:2.22B
PE:-12.90
High:20.50
Open:19.39
Low:19.25
Close:19.26
Loading ...
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 17, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 15, 2024

Major Issues Report

Form 8-K - Current report
Sep 03, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jul 25, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jul 25, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jul 25, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jul 25, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Jul 25, 2024

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments